Symbol: |
CACNG2
|
Description: |
calcium channel, voltage-dependent, gamma subunit 2 [Source:HGNC Symbol;Acc:1406]
|
Location: |
Chr22:36959968-37099603[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:50
Gene |
Compound |
Gen_sig |
Exp_pattern |
CACNG2 |
NSC 671002 |
0.009 |
Up |
CACNG2 |
NSC 672768 |
0.04 |
Down |
CACNG2 |
NSC 673507 |
0.019 |
Down |
CACNG2 |
1H-Dipyrazolo[1,5-a:4',3'-e]pyrimidine-3,4,7-triamine, 6-[(4-bromophenyl)azo]- |
0.032 |
Up |
CACNG2 |
NSC 674182 |
0.042 |
Up |
CACNG2 |
10H-Phenothiazine, 1,3,4-trifluoro-2-nitro- |
0.034 |
Up |
CACNG2 |
NSC 677810 |
0.033 |
Up |
CACNG2 |
Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-3-[(ethoxy-carbonyl)methyl]-, trans- |
0.022 |
Up |
CACNG2 |
2-[(4-Methylphenyl)sulfinyl]-3-furancarboxaldehyde |
0.049 |
Up |
CACNG2 |
Z(OMe)-Gly-Ala-Phe-OBzl |
0.033 |
Up |
CACNG2 |
NSC 681175 |
0.029 |
Up |
CACNG2 |
NSC 683555 |
0.022 |
Up |
CACNG2 |
NSC 694461 |
0.019 |
Down |
CACNG2 |
NSC 694964 |
0.04 |
Down |
CACNG2 |
NSC 696076 |
0.022 |
Down |
Expression pattern: Sensitivity / Resistance
Total:4 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:76
Total:6 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:5
Gene |
Gen_transcript |
miRNA |
miR_location |
CACNG2 |
ENST00000300105 |
hsa-mir-493-5p |
Chr14:101335412-101335433[+] |
CACNG2 |
ENST00000300105 |
hsa-mir-523-5p |
Chr19:54201654-54201675[+] |
CACNG2 |
ENST00000300105 |
hsa-mir-638 |
Chr19:10829095-10829119[+] |
CACNG2 |
ENST00000300105 |
hsa-mir-658 |
Chr22:38240294-38240318[-] |
CACNG2 |
ENST00000300105 |
hsa-mir-663a |
Chr20:26188879-26188900[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|